Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology

Terri Rice, Shichun Zheng, Paul A. Decker, Kyle M. Walsh, Paige Bracci, Yuanyuan Xiao, Lucie S. McCoy, Ivan Smirnov, Joseph S. Patoka, Helen M. Hansen, George Hsuang, Joe L. Wiemels, Tarik Tihan, Alexander R. Pico, Michael D. Prados, Susan M. Chang, Mitchel S. Berger, Alissa Caron, Stephanie Fink, Thomas KollmeyerAmanda Rynearson, Jesse Voss, Matthew L. Kosel, Brooke L. Fridley, Daniel H. Lachance, Jeanette E. Eckel-Passow, Hugues Sicotte, Brian Patrick O'Neill, Caterina Giannini, John K. Wiencke, Robert B. Jenkins, Margaret R. Wrensch

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

IntroductionRecent discoveries of inherited glioma risk loci and acquired IDH mutations are providing new insights into glioma etiology. IDH mutations are common in lower grade gliomas and secondary glioblastomas and uncommon in primary glioblastomas. Because the inherited variant in 11q23 has been associated with risk of lower grade glioma and not with glioblastomas, we hypothesized that this variant increases susceptibility to IDH-mutated gliomas, but not to IDH-wild-type gliomas.MethodsWe tested this hypothesis in patients with glioma and controls from the San Francisco Adult Glioma Study, the Mayo Clinic, and Illumina controls (1102 total patients, 5299 total controls). Case-control additive associations of 11q23 risk alleles (rs498872, T allele) were calculated using logistic regression, stratified by tumor IDH status (mutated or wild-type) and by histology and grade. We also adjusted for the recently discovered 8q24 glioma risk locus rs55705857 G allele.ResultsThe 11q23 glioma risk locus was associated with increased risk of IDH-mutated gliomas of all histologies and grades (odds ratio [OR] = 1.50; 95% confidence interval [CI] = 1.29-1.74; P = 1.3X10-7) but not with IDH-wild-type gliomas of any histology or grade (OR = 0.91; 95% CI = 0.81-1.03; P = 0.14). The associations were independent of the rs55705857 G allele.ConclusionA variant at the 11q23 locus increases risk for IDH-mutated but not IDH-wild-type gliomas, regardless of grade or histology.

Original languageEnglish (US)
Pages (from-to)535-541
Number of pages7
JournalNeuro-oncology
Volume15
Issue number5
DOIs
StatePublished - May 2013

Keywords

  • IDH1 and IDH2 mutation
  • adult glioma
  • rs498872
  • rs55705857
  • single-nucleotide polymorphism

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Fingerprint Dive into the research topics of 'Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology'. Together they form a unique fingerprint.

  • Cite this

    Rice, T., Zheng, S., Decker, P. A., Walsh, K. M., Bracci, P., Xiao, Y., McCoy, L. S., Smirnov, I., Patoka, J. S., Hansen, H. M., Hsuang, G., Wiemels, J. L., Tihan, T., Pico, A. R., Prados, M. D., Chang, S. M., Berger, M. S., Caron, A., Fink, S., ... Wrensch, M. R. (2013). Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology. Neuro-oncology, 15(5), 535-541. https://doi.org/10.1093/neuonc/nos324